Skip to main content

Table 1 Characteristics of the patients in the different groups

From: Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells

 

Healthy

Disease controls

Patients with RA

Number of individuals

152

236

347

Female), n (%)

107 (70.4)

115 (48.7)

277 (79.8)

Age, median (range)

57 (23–71)

47 (18–85)

58 (21 − 94)

Anti-CCP2, n (%)

5 (3.3)

10 (4.2)

250 (72.0)

Anti-cit-Fib protein, n (%)

NA

NA

190 (54.9)

  1. RA rheumatoid arthritis, CCP cyclic citrullinated peptides, cit-Fib citrullinated fibrinogen, NA data not available
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us